InvestorsHub Logo
Followers 270
Posts 31872
Boards Moderated 0
Alias Born 11/14/2013

Re: None

Wednesday, 08/30/2023 6:01:55 PM

Wednesday, August 30, 2023 6:01:55 PM

Post# of 673889
NWBO has recently conveyed to the public, which includes the opposition:

1. They are in active negotiations with other companies regarding combination trials.

2. They have completed each and every precondition to filing an MAA.

3. They anticipate submitting an MAA in late September to early October.

4. Advent have all manufacturing licenses for clinical, specials and commercial cellular manufacturing.

5. Their manufacturing capacity has increased with the latest expansion.

6. They have responded to the motion to dismiss by crushing defendants’ arguments, including but not limited to pointing out the defendants, as their prior argument, have complacently relied upon overturned precedent.

7. They intend on expanding DCVax-l use to all solid tumors.

8. Meanwhile, the FDA announced final guidance for real world evidence usage in the approval process.

9. And newsflash, as TDD just posted, the Feds intend to increase their efforts against
Illegal shorting over the next few months, particularly related to hedge funds using articles in coordination with shorting. The Feds also intend to continue their efforts against spoofing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News